Bryologyx

0 followers

‌

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.

Industries

Headquarters

Employees

Links

Org chart

Co-Founder, CEO & Director

Thomas M. Loarie

Collapse

CFO

General Counsel

Co-Founder, Director & VP, R&D

VP, Clinical Development & Logistics

Director, Pharmaceutical Development

Senior Scientist, Immunology

14 members

9 members

4 members

2 members

Motive

17 followers

Jack Morton Worldwide

3 followers

Secureworks

7 followers

Excellus BCBS

4 followers

Itron

12 followers

Discover companies